Ivana Magovcevic-Liebisch - Jan 6, 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
President and CEO, Director
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 07:34 PM
Previous filing
Dec 2, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VIGL Common Stock 199K Jan 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VIGL Stock Option Grant (Right to Buy) Jan 6, 2022 Common Stock 369K $1.89 Direct F1
holding VIGL Stock Option Grant (Right to Buy) Jan 6, 2022 Common Stock 211K $1.89 Direct F2
holding VIGL Stock Option Grant (Right to Buy) Jan 6, 2022 Common Stock 405K $6.02 Direct F3
holding VIGL Stock Option Grant (Right to Buy) Jan 6, 2022 Common Stock 43.3K $9.57 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option vested and became exercisable on July 10, 2021, with the remainder vesting in 36 equal monthly installments thereafter.
F2 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested May 28, 2021.
F3 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested September 13, 2021.
F4 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested November 14, 2021.

Remarks:

Exhibit 24 - Power of Attorney